Finbar O'Callaghan's publicationsArticles:
2011: O'Callaghan, FJK, Lux, AL, Darke, K, Edwards, SW, Hancock, E, Johnson, AL, Kennedy, CR, Newton, RW, Verity, CM & Osborne, JP. The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: Evidence from the United Kingdom Infantile Spasms Study. Epilepsia, July, 52(7):1359-1364.
2011: Edwards RJ, Allport TD, Stoodley NG, O'Callaghan FJK, Lock RJ, Carter MR & Ramanan AV. External hydrocephalus and subdural bleeding in infancy associated with transplacental anti-Ro antibodies. Archives of Disease in Childhood. April 2011 (Epub ahead of print).
2011: Mackay MT, Wiznitzer M, Benedict SL, Lee KJ, deVeber GA & Ganesan V on behalf of the International Pediatric Stroke Study Group. Arterial ischemic stroke risk factors: The international pediatric stroke study', Annals of Neurology, Jan, 69(1):130-140.
2011: Fong CY, Rolfs A, Schwarzbraun T, Klein C, O'Callagha, FJK. Juvenile Parkinsonism associated with heterozygous frameshift ATP13A2 gene mutation, Eur J Paediatr Neurol. Feb 11 2011 (Epub ahead of print.)
2011: Kurian MA, Li Y, Zhen J, Meyer E, Hai NA, Christen HJ, Hoffmann GF, Jardine, PE, von Moers A, Mordekar SR, O'Callaghan FJK, Wassmer E, Wraige E, Dietrich C, Lewis T, Hyland K, Heales SJ, Sanger T, Gissen P, Assmann BE, Reith ME & Maher ER. Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study. Lancet Neurology Jan, 10(1):24-5.
2010: Kurian MA, Meyer E, Vassallo G, Morgan NV, Prakash N, Pasha S, Hai NA, Shuib S, Rahman F, Wassmer E, Cross JH, O'Callaghan FJ, Osborne JP, Scheffer IE, Gissen P, Maher ER. Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy. Brain Sept 9 2010 (Epub ahead of print).
2010: Osborne JP, Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, Verity CM, O'Callaghan FJK. The underlying etiology of infantile spasms (West syndrome): Information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification. Epilepsia Aug 17 2010 (Epub ahead of print).
2010: Mallick AA, O'Callaghan FJK. Risk factors and treatment outcomes of childhood stroke. Expert Review of Neurotherapeutics 10(8): 1331-1346.
2010: Darke K, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Lux AL, Newton RW, O'Callaghan, FJK, Verity CM & Osborne JP. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial. Archives of Disease in Childhood 95(5): 382-6.
2010: Jordan LC, Rafay MF, Smith SE, Askalan R, Zamel KM, deVeber G, Ashwal S & International Paediatric Stroke Study Group. Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the International Pediatric Stroke Study. Journal of Paediatrics 156(5): 704-710.
Sen ES, Leone V, Abinun M, Forsyth R, Ramesh V, Friswell M, O'Callaghan F, Ramanan AV. Treatment of primary angiitis of the central nervous system in childhood with mycophenolate mofetil. Rheumatology 49(4): 806-811
Mallick AA, Ganesan V, O’Callaghan FJ. Mortality from childhood stroke in England and Wales 1921-2000. Archives of Disease in Childhood 95(1): 12-19.
2010: Mallick AA, O’Callaghan FJ. The epidemiology of childhood stroke. European Journal of Paediatric Neurology 14(3): 197-205.
2009:
2009: Osborne JP, O’Callaghan FJ. Running an international paediatric non-commercial clinical trial. Archives of Disease in Childhood 94(9): 729-733.
2009: Mallick AA, O’Callaghan FJ. Research governance delays for a multi-centre, non-interventional study. Journal of Royal Society of Medicine 102(5): 195-198.
2009: Mallick AA, Sharples PM, Calvert SE, Jones RW, Leary M, Lux AL, O’Callaghan FJ, Osborne JP, Patel JS, Prendiville AT, Renowden S, Jardine PE. Cerebral venous sinus thrombosis: a case series including thrombolysis. Archives of Disease in Childhood 94(10): 790-4.
2009: Amelie-Lefond C et al and International Paediatric Stroke Study. Use of alteplase in childhood arterial ischaemic stroke: a multicentre observational cohort study. Lancet Neurology 8(6): 530-36.
2009: Golomb MR et al. and International Paediatric Stroke Study. Male predominance in childhood ischemic stroke: findings from the international pediatric stroke study. Stroke 40(1): 52-7.
2008: O’Callaghan FJ, Martyn CN, Renowden S, Noakes M, Presdee D, Osborne JP. Sub-ependymal nodules, giant cell astrocytomas and the tuberous sclerosis complex – a population based study. Archives of Disease in Childhood 93(9): 751-4
2008: Osborne JP, Merrifield J, O’Callaghan FJ. Tuberous sclerosis complex - what's new? Archives of Disease in Childhood 93(9): 728-31
2008: Gale CR, Robinson SM, Godfrey KM, Law CM, Schlotz W, O’Callaghan FJ. Oily fish intake during pregnancy--association with lower hyperactivity but not with higher full-scale IQ in offspring. Journal of Child Psychology and Psychiatry. 49(10): 1061-8.
2008: O’Callaghan FJ. Tuberous sclerosis complex. Paediatrics and Child Health 18(1): 30-36.
2006: Raznahan A, Joinson C, O’Callaghan F, Osborne JP, Bolton PF. Psychopathology in tuberous sclerosis: an overview and findings in a population-based sample of adults with tuberous sclerosis. Journal of Intellectual Disability Research. 50(Pt 8): 561-569.
2006: Archer HL, Evans JC, Newbury-Ecob R, O’Callaghan F, Osborne J et al. CDKL5 mutations cause infantile spasms, early onset seizures and severe mental retardation in female patients. J Med Genet 43(9): 729-34.
2006: Gale CR, O’Callaghan FJ, Bredow M, Golding J, Martyn CN and the ALSPAC Study Group. The influence of brain growth in fetal life, infancy and childhood on intelligence at age four and eight years. Pediatrics. 118(4): 1486-92
2006: Silva AAM, Mehta Z, O’Callaghan FJ. Duration of breast feeding and cognitive function: comparing estimates derived from multiple linear regression and structural equation modeling. European Journal of Epidemiology. 21(6): 435-41.
2006: Silva AAM, Mehta Z, O’Callaghan FJ. The relative effect of size at birth, post-natal growth and social factors on cognitive function in late childhood. Annals of Epidemiology. 16(6): 469-76.
2005: Lux A, Edwards S, Hancock E, Johnson A, Kennedy C, Newton R, O’Callaghan F, Verity C, Osborne J. The United Kingdom Infantile Spasm Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes at 14 months: a multicentre randomised trial. Lancet Neurol. 4(11): 712-7.
2005: Basu H, O’Callaghan FJ. Status Epilepticus: beyond guidelines. Current Paediatrics 15(4): 324-332.
2005: Hancock E, O’Callaghan FJ, English J, Osborne JP. Melatonin excretion in normal children and in tuberous sclerosis with sleep disorder responsive to melatonin. Journal of Child Neurology 20(1): 21-25.
2005: Hancock E, O’Callaghan FJ, English J, Osborne JP. Effect of Melatonin dosage on sleep disorder in tuberous sclerosis. Journal of Child Neurology 20(1): 78-80
2004: Gale CR, O’Callaghan FJ, Godfrey KM, Law CM, Martyn CN. Critical periods of brain growth and cognitive function in children. Brain 127(2): 321-329.
2004: Lux A, Edwards S, Hancock E, Johnson A, Kennedy C, Newton R, O’Callaghan F, Verity C, Osborne J. The United Kingdom Infantile Spasm Study (UKISS) comparing vigabatrin with prednisolone or tetracosactride in West Syndrome in a randomised trial: the control of infantile spasms at 14 days. The Lancet 364(9447): 1773-8.
2004: O’Callaghan FJ, Noakes M, Martyn CN, Osborne JP. An epidemiological study of renal pathology in tuberous sclerosis complex. British Journal of Urology 94(6): 853-7
2004: O’Callaghan FJK, Osborne JP, Martyn CN. Epilepsy-related mortality. Archives of Disease in Childhood 89(8): 705-707.
2004: O’Callaghan FJK, Joinson C, Bolton P, Noakes M, Renowden S, Shiell A, Martyn CN, Osborne JP. The relationship of infantile spasms, tubers, and intelligence in tuberous sclerosis complex. Archives of Disease in Childhood 89(6): 530-533.
2003: Joinson C, O’Callaghan FJK, Osborne JP, Martyn CN, Harris T, Bolton PF. Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychological Medicine 33(2): 335-344
2003: Osborne JP, O’Callaghan FJ. The management of tuberous sclerosis. Current Paediatrics 13: 365-370.
2002: O’Callaghn FJK. Autism: what is it and where does it come from? (Editorial) Quarterly Journal of Medicine 95: 263-265
2001: Rowley S, O'Callaghan FJK, Osborne JP. The ophthalmic manifestations of tuberous sclerosis complex: a population based study. British Journal of Ophthalmology 85(4): 420-423.
O’Callaghan FJ, Needham C, Renowden S, Noakes MJ, Martyn CN, Bolton PF, Osborne JP. Evidence that in tuberous sclerosis infantile spasms result in learning difficulty independently of the effect of cerebral pathology. Epilepsia 42 (suppl 7): 105.
2001: O’Callaghan FJK, Renowden S, Noakes M, Osborne JP. Prevalence of subependymal giant cell astrocytomas in tuberous sclerosis complex patients in the Wessex region. Developmental Medicine and Child Neurology 42 (suppl 85): 7.
2001: O'Callaghan FJK, Osmond C, Martyn C. Trends in epilepsy mortality in England and Wales and the United States of America 1950-94. American Journal of Epidemiology 151(2): 182-189.
2000: O'Callaghan FJK, Osborne JP. Advances in the understanding of tuberous sclerosis. Archives of Disease in Childhood 83(2): 140-142.
2000: O’Callaghan FJK, Renowden S, Needham C, Harris T, Noakes M, Bolton P, Martyn CN, Osborne JP. Cerebral pathology and cognitive function in individuals with normal intellect with tuberous sclerosis. Developmental Medicine and Child Neurology 41 (suppl 82): 22.
2000: Osborne JP, Jones AC, Burley MW Jeganathan D, Young J, O'Callaghan FJ, Sampson JR, Povey S. Non-penetrance in tuberous sclerosis. Lancet 355: 1698.
2000: O'Callaghan FJK, Noakes M, Osborne JP. Renal angiomyolipomata and learning difficulty in tuberous sclerosis complex. Journal of Medical Genetics 37(2): 156-157.
1999: Harrison JE, O'Callaghan F, Hancock E, Bolton P, Osborne JP. Cognitive deficits in normally intelligent patients with tuberous sclerosis. American Journal of Medical Genetics 88(6): 642-646.
1999: O'Callaghan FJK. Tuberous Sclerosis (Editorial). British Medical Journal 318: 1019-1020.
1999: O'Callaghan FJK, Clarke AC, Hancock EC, Arendt J, English J., Osborne JP. Use of melatonin to treat sleep disorders in tuberous sclerosis. Developmental Medicine and Child Neurology 41: 123-126.
1998: O'Callaghan FJK, Clarke AC, Joffe H, Keeton B, Martin R, Salmon A, Thomas RD, Osborne JP. Tuberous Sclerosis Complex and Wolff Parkinson White Syndrome. Archives of Disease in Childhood 78: 159-162.
1998: O'Callaghan FJK, Shiell AW, Osborne JP, Martyn CN. Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet 351: 1490.
1998: O'Callaghan FJK, Osmond C, Martyn C. Trends in epilepsy mortality in England and Wales and the United States of America 1950-94. Epilepsia 39(sup 6): 183.
1989: O'Callaghan F, Padkin AJ. High Frequency Oscillation: An investigation into its use in the surfactant-deficient lung. Archives of Disease in Childhood 64: 1220.
1989: Walker CS, Padkin AJ, O'Callaghan F, Bryan AC. The Effect of High Frequency Oscillation on PaO2 and Cardiac Output. American Review of Respiratory Diseases 139(4): A442 |
Home 
Publications Publications: Finbar O'Callaghan
Publications Publications: Finbar O'Callaghan
Research
| Projects |
| Publications |